Market Cap 9.40B
Revenue (ttm) 4.05B
Net Income (ttm) 22.20M
EPS (ttm) N/A
PE Ratio 17.46
Forward PE 18.38
Profit Margin 0.55%
Debt to Equity Ratio 0.69
Volume 1,741,700
Avg Vol 909,666
Day's Range N/A - N/A
Shares Out 49.21M
Stochastic %K 92%
Beta 1.50
Analysts Sell
Price Target $187.15

Company Profile

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of serv...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 222 6000
Address:
251 Ballardvale Street, Wilmington, United States
OptionRunners
OptionRunners Oct. 24 at 5:50 PM
$CRL calls are trading $22+ now. Some profit taking in them over the last couple of days though. OI down to 449.
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 24 at 3:54 PM
🏛️ 🚀 $CRL up ⬆️36.50% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
ZacksResearch
ZacksResearch Oct. 24 at 2:02 PM
$CRL Q3 earnings preview — can they keep the streak alive? 📊 Charles River has beaten EPS estimates in each of the last four quarters, with an impressive average surprise of 12.84%. For Q3, the Zacks Consensus Estimate suggests a 10.4% YoY EPS decline, but a +0.61% Earnings ESP and Zacks Rank #3 hint at another possible beat. Find out if CRL can defy expectations again 👉 https://www.zacks.com/stock/news/2776176/heres-how-charles-river-stock-is-placed-ahead-of-q3-earnings?cid=sm-stocktwits-2-2776176-body-17480&ADID=SYND_STOCKTWITS_TWEET_2_2776176_BODY_17480
0 · Reply
ZacksResearch
ZacksResearch Oct. 24 at 1:02 PM
$CRL — positioned for a potential earnings surprise? 👀 The preview dives into how Charles River’s setup looks heading into its Q3 report, analyzing key factors that could shape its performance and investor sentiment. Full pre-earnings breakdown here 👉 https://www.zacks.com/stock/news/2776176/heres-how-charles-river-stock-is-placed-ahead-of-q3-earnings?cid=sm-stocktwits-2-2776176-teaser-17469&ADID=SYND_STOCKTWITS_TWEET_2_2776176_TEASER_17469
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 23 at 2:31 PM
🏛️ 🚀 $CRL up ⬆️33.44% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 20 at 10:13 PM
🏛️ 🚀 $CRL up ⬆️25.96% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
vjtweet
vjtweet Oct. 20 at 8:19 PM
$CRL closed half position.
0 · Reply
StockAutoPro
StockAutoPro Oct. 18 at 4:14 AM
$CRL: Buy target $177.49 Sell target $188.46 Strong clinical trial results suggest potential growth for this animal healthcare stock.
0 · Reply
OptionRunners
OptionRunners Oct. 17 at 7:37 PM
$CRL Buyer of the November 21st $180 calls 500 times for $11.00 ahead of earnings on 11/5
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 7:37 PM
Enter: $CRL NOV 21 2025 $175 CALLS Buy in Price: $10.40 - $11.90 Take Profit: $19.03 Stop Bleeding: $9.15 ROI Potential: 83% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
Latest News on CRL
Why Charles River Stock May Struggle In Its Final Phase

Oct 7, 2025, 7:22 AM EDT - 18 days ago

Why Charles River Stock May Struggle In Its Final Phase


Charles River: Margin Fears Outweigh Solid Q2

Aug 6, 2025, 12:47 PM EDT - 2 months ago

Charles River: Margin Fears Outweigh Solid Q2


Charles River Laboratories Announces First-Quarter 2025 Results

May 7, 2025, 7:01 AM EDT - 6 months ago

Charles River Laboratories Announces First-Quarter 2025 Results


OptionRunners
OptionRunners Oct. 24 at 5:50 PM
$CRL calls are trading $22+ now. Some profit taking in them over the last couple of days though. OI down to 449.
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 24 at 3:54 PM
🏛️ 🚀 $CRL up ⬆️36.50% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
ZacksResearch
ZacksResearch Oct. 24 at 2:02 PM
$CRL Q3 earnings preview — can they keep the streak alive? 📊 Charles River has beaten EPS estimates in each of the last four quarters, with an impressive average surprise of 12.84%. For Q3, the Zacks Consensus Estimate suggests a 10.4% YoY EPS decline, but a +0.61% Earnings ESP and Zacks Rank #3 hint at another possible beat. Find out if CRL can defy expectations again 👉 https://www.zacks.com/stock/news/2776176/heres-how-charles-river-stock-is-placed-ahead-of-q3-earnings?cid=sm-stocktwits-2-2776176-body-17480&ADID=SYND_STOCKTWITS_TWEET_2_2776176_BODY_17480
0 · Reply
ZacksResearch
ZacksResearch Oct. 24 at 1:02 PM
$CRL — positioned for a potential earnings surprise? 👀 The preview dives into how Charles River’s setup looks heading into its Q3 report, analyzing key factors that could shape its performance and investor sentiment. Full pre-earnings breakdown here 👉 https://www.zacks.com/stock/news/2776176/heres-how-charles-river-stock-is-placed-ahead-of-q3-earnings?cid=sm-stocktwits-2-2776176-teaser-17469&ADID=SYND_STOCKTWITS_TWEET_2_2776176_TEASER_17469
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 23 at 2:31 PM
🏛️ 🚀 $CRL up ⬆️33.44% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 20 at 10:13 PM
🏛️ 🚀 $CRL up ⬆️25.96% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
vjtweet
vjtweet Oct. 20 at 8:19 PM
$CRL closed half position.
0 · Reply
StockAutoPro
StockAutoPro Oct. 18 at 4:14 AM
$CRL: Buy target $177.49 Sell target $188.46 Strong clinical trial results suggest potential growth for this animal healthcare stock.
0 · Reply
OptionRunners
OptionRunners Oct. 17 at 7:37 PM
$CRL Buyer of the November 21st $180 calls 500 times for $11.00 ahead of earnings on 11/5
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 7:37 PM
Enter: $CRL NOV 21 2025 $175 CALLS Buy in Price: $10.40 - $11.90 Take Profit: $19.03 Stop Bleeding: $9.15 ROI Potential: 83% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 1:18 PM
Mizuho updates rating for Charles River ( $CRL ) to Neutral, target set at 155 → 174.
0 · Reply
vjtweet
vjtweet Oct. 16 at 5:00 PM
$CRL has a position. Showing good relative strength today.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 16 at 1:26 PM
$CRL Share Price: $170.72 Contract Selected: Feb 20, 2026 $170 Calls Buy Zone: $15.30 – $18.90 Target Zone: $25.65 – $31.35 Potential Upside: 58% ROI Time to Expiration: 126 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
vjtweet
vjtweet Oct. 13 at 7:48 PM
Not worth holding big over night positions.. don't fall for FOMO. Yet $CRL looks ok here. Small position.
0 · Reply
TalkMarkets
TalkMarkets Oct. 12 at 7:00 PM
3 #Medical Service #Industry #Stocks Poised To Counter Workforce Issues $CRL $LH $TDOC https://talkmarkets.com/content/stocks--equities/3-medical-service-industry-stocks-poised-to-counter-workforce-issues?post=527878&userid=123969
0 · Reply
RunnerSignals
RunnerSignals Oct. 7 at 10:27 PM
Wall Street turning bullish! $AMD $LRCX $CRL $HOLX $EME all caught upgrades today. LRCX seeing the biggest love with a $150 PT that's a 50% jump from $100 https://stocksrunner.com/news/2025-10-07-wall-street-analysts-signal-strong-buys
0 · Reply
StockAutoPro
StockAutoPro Oct. 6 at 4:47 PM
$CRL: Buy target $177.49 Sell target $188.46 Strong clinical trial results suggest potential growth for this animal healthcare stock.
0 · Reply
JarvisFlow
JarvisFlow Oct. 6 at 3:27 PM
William Blair has adjusted their stance on Charles River ( $CRL ), setting the rating to Outperform.
0 · Reply
Mrstock2255
Mrstock2255 Oct. 6 at 3:14 PM
$CRL how many? And your people 0!
0 · Reply
IN0V8
IN0V8 Oct. 3 at 4:30 PM
$CRL Barclays raises target price to $195 from $165 Barclays raises to overweight from equal-weight
0 · Reply
JarvisFlow
JarvisFlow Oct. 3 at 3:59 PM
Evercore ISI Group has updated their rating for Charles River ( $CRL ) to Outperform with a price target of 200.
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 12:13 PM
$CRL: Unusual Options Activity Alerted PUT flow observed 100x contracts at Strike price of $150 Exp on 11/21/2025 with Premium of $40K and showing BEARISH Sentiment
0 · Reply